www.BuyersGuideChem.com - the directory of chemicals and chemical suppliers. The search engine opens a large data base and offers new supply sources
Welcome About BGC Terms of Use MSDS Banner Adverts Statistics Impressum Sitemap
BGC > Product Search > Renzapride | 112727-80-7
english deutsch espaņol

Suppliers for

Renzapride



Properties

CAS   112727-80-7 

Structure

6 Registered suppliers


Molecular Formula: C16H23Cl2N3O2
Molecular Weight: 360.27872

Description :
Renzapride is a full 5-HT4 agonist and partial 5-HT3 antagonist. Renzapride has been used for the treatment of constipation-predominant irritable bowel syndrome (IBS-C).
  • Molecular Weight :323.82
  • Boiling Point :469.2ēC at 760mmHg
  • Purity :95%
Molecular Formula :
C16H22ClN3O2
Canonical SMILES :
COC1=CC(=C(C=C1C(=O)NC2CCN3CCCC2C3)Cl)N
InChI :
InChI=1S/C16H22ClN3O2/c1-22-15-8-13(18)12(17)7-11(15)16(21)19-14-4-6-20-5-2-3-10(14)9-20/h7-8,10,14H,2-6,9,18H2,1H3,(H,19,21)/t10-,14+/m0/s1
InChIKey :
GZSKEXSLDPEFPT-IINYFYTJSA-N
Application :
Serotonin Antagonists
Synonyms :
Renzapridum; Benzamide, 4-amino-N-(1R,4S,5R)-1-azabicyclo[3.3.1]non-4-yl-5-chloro-2-methoxy-, rel-

More details are to be found here
Description :
Renzapride is a full 5-HT4 agonist and partial 5-HT3 antagonist. Renzapride has been used for the treatment of constipation-predominant irritable bowel syndrome (IBS-C).
  • Molecular Weight :323.82
  • Boiling Point :469.2ēC at 760mmHg
  • Purity :95%
Molecular Formula :
C16H22ClN3O2
Canonical SMILES :
COC1=CC(=C(C=C1C(=O)NC2CCN3CCCC2C3)Cl)N
InChI :
InChI=1S/C16H22ClN3O2/c1-22-15-8-13(18)12(17)7-11(15)16(21)19-14-4-6-20-5-2-3-10(14)9-20/h7-8,10,14H,2-6,9,18H2,1H3,(H,19,21)/t10-,14+/m0/s1
InChIKey :
GZSKEXSLDPEFPT-IINYFYTJSA-N
Application :
Serotonin Antagonists
Synonyms :
Renzapridum; Benzamide, 4-amino-N-(1R,4S,5R)-1-azabicyclo[3.3.1]non-4-yl-5-chloro-2-methoxy-, rel-

More details are to be found here

Detailed information on the suppliers of Renzapride

Properties:

... more properties and specification on Renzapride
Š Copyright 1996 to 2024 by Netvertise GmbH. All rights reserved